Rosiglitazone and Metformin Clinical Trials

• Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects
  ClinicalTrials.gov Identifier: NCT00499707 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00367055 - Active, not recruiting
  Type 2 Diabetes
  
• Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY)
  ClinicalTrials.gov Identifier: NCT00081328 - Recruiting
  Diabetes Mellitus, Type II
  
• Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients with Insulin and Fat Abnormalities
  ClinicalTrials.gov Identifier: NCT00015691 - Completed
  HIV Infections; Lipodystrophy; Hyperinsulinemia
  
• Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)
  ClinicalTrials.gov Identifier: NCT00110851 - Completed
  Type 2 Diabetes Mellitus
  
• To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together
  ClinicalTrials.gov Identifier: NCT00318461 - Active, not recruiting
  Type 2 Diabetes
  
• A Lifestyle and Combination Medication Therapy Diabetes Prevention Study
  ClinicalTrials.gov Identifier: NCT00116922 - Active, not recruiting
  Glucose Metabolism Disorder; Diabetes
  
• South Danish Diabetes Study
  ClinicalTrials.gov Identifier: NCT00121966 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)
  ClinicalTrials.gov Identifier: NCT00032487 - Active, not recruiting
  Type 2 diabetes mellitus
  
• Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study
  ClinicalTrials.gov Identifier: NCT00343395 - Not yet recruiting
  Coronary Artery Disease
  
• Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00399711 - Completed
  Diabetes Mellitus, Type 2
  
• A Randomised Trial of Rosiglitazone Versus Metformin Monotherapy in Indigenous Australians With Type 2 Diabetes: Effects on Metabolic and Cardiovascular Parameters
  ClinicalTrials.gov Identifier: NCT00437970 - Not yet recruiting
  Diabetes Mellitus, Type 2
  
• Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO
  ClinicalTrials.gov Identifier: NCT00362323 - Recruiting
  Dyslipidemia; Glucose Metabolism Disorder
  
• Metformin Obesity Study
  ClinicalTrials.gov Identifier: NCT00120146 - Active, not recruiting
  Obesity
  
• Treating Nonalcoholic Steatohepatitis (NASH) with Metformin
  ClinicalTrials.gov Identifier: NCT00063232 - Recruiting
  Hepatitis
  
• Effect of Metformin in Patients with Type-1 Diabetes with Inadequate Glycaemic Control by Insulin and Diet
  ClinicalTrials.gov Identifier: NCT00118937 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
  ClinicalTrials.gov Identifier: NCT00279045 - Completed
  Non-Insulin-Dependent Diabetes Mellitus
  
• Insulin Glargine v Rosiglitazone as Add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy
  ClinicalTrials.gov Identifier: NCT00358124 - Completed
  Type 2 Diabetes Mellitus
  
• Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00434954 - Recruiting
  Type 2 Diabetes Mellitus
  
• Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone
  ClinicalTrials.gov Identifier: NCT00396357 - Recruiting
  Diabetes Mellitus, Type 2
  
• Rosiglitazone Plaque Study
  ClinicalTrials.gov Identifier: NCT00123227 - Active, not recruiting
  Diabetes Mellitus, Type 2; Vascular Diseases; Hypertension
  
• Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes
  ClinicalTrials.gov Identifier: NCT00118963 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Avandia™ + Amaryl™ or Avandamet™ Compared with Metformin (AVALANCHE™ Study)
  ClinicalTrials.gov Identifier: NCT00131664 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Rosiglitazone in Treating Patients With Liposarcoma
  ClinicalTrials.gov Identifier: NCT00004180 - Active, not recruiting
  adult liposarcoma; recurrent adult soft tissue sarcoma
  
• Rosiglitazone-Induced Weight Gain
  ClinicalTrials.gov Identifier: NCT00225225 - Recruiting
  Type 2 Diabetes Mellitus
  
• The DREAM (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) Trial
  ClinicalTrials.gov Identifier: NCT00095654 - Active, not recruiting
  Impaired Glucose Tolerance; Cardiovascular Disease; Glucose Metabolism Disorders
  
• Metformin to Treat Obesity in Children with Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00005669 - Recruiting
  Hyperinsulinemia; Obesity
  
• Metformin in Pregnant PCOS Women.
  ClinicalTrials.gov Identifier: NCT00159536 - Recruiting
  Polycystic Ovary Syndrome
  
• Double Blinded Randomised Trial Comparing Metformin Versus Placebo in NASH Patients Receiving Bariatric Surgery for Obesity
  ClinicalTrials.gov Identifier: NCT00134303 - Recruiting
  Obesity
  
• Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone
  ClinicalTrials.gov Identifier: NCT00402909 - Completed
  Type 2 Diabetes
  
• Lifestyle Intervention and Metformin for Women with PCOS
  ClinicalTrials.gov Identifier: NCT00151411 - Recruiting
  Polycystic Ovary Syndrome
  
• Rosiglitazone Versus Placebo in Chronic Stable Angina
  ClinicalTrials.gov Identifier: NCT00225355 - Recruiting
  Angina Pectoris; Metabolic Syndrome X
  
• Rosiglitazone versus Glipizide on Progression of Atherosclerosis in Patients with Cardiovascular Disease and Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00116831 - Recruiting
  Non-Insulin-Dependent Diabetes Mellitus
  
• Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels
  ClinicalTrials.gov Identifier: NCT00143624 - Recruiting
  HIV Metabolic Syndrome; Atherosclerosis in HIV
  
• The Effects of Metformin on Blood Vessel Structure and Function
  ClinicalTrials.gov Identifier: NCT00105066 - Recruiting
  Obesity; Hypertension; Hypercholesterolemia; Hyperglycemia
  
• Rosiglitazone for Clozapine Induced Glucose Metabolism Impairment
  ClinicalTrials.gov Identifier: NCT00337350 - Active, not recruiting
  Schizophrenia
  
• The Effect of Metformin in Overweight Patients with Dysregulated Type 1 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00145379 - Recruiting
  Type 1 diabetes mellitus
  
• The Influence of Rosiglitazone on the Diuretic Effect of Furosemide and Amiloride
  ClinicalTrials.gov Identifier: NCT00285805 - Active, not recruiting
  Insulin Resistance
  
• Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00519142 - Recruiting
  Diabetes Mellitus, Type 2
  
• Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI
  ClinicalTrials.gov Identifier: NCT00361868 - Terminated
  Dyslipidemia; Glucose Metabolism Disorder
  
• Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride
  ClinicalTrials.gov Identifier: NCT00424762 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• The Study of Atherosclerosis with Ramipril and Rosiglitazone
  ClinicalTrials.gov Identifier: NCT00140647 - Active, not recruiting
  Atherosclerosis; Impaired Glucose Tolerance; isolated impaired fasting glucose; Cardiovascular Disease
  
• An Evaluation of Exenatide and Rosiglitazone in Subjects with Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00135330 - Recruiting
  Diabetes Mellitus, Type 2
  
• Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or Rosiglitazone
  ClinicalTrials.gov Identifier: NCT00282945 - Terminated
  Type 2 Diabetes Mellitus
  
• Rosiglitazone and Mild Cognitive Impairment (MCI)
  ClinicalTrials.gov Identifier: NCT00242593 - Recruiting
  Mild Cognitive Impairment
  
• Effects of Metformin HCl in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus Not Previously Treated With Drug Therapy, and the Effects of Colesevelam HCl on Lipids (e.g., Cholesterol) and Glucose
  ClinicalTrials.gov Identifier: NCT00570739 - Recruiting
  Type 2 Diabetes Mellitus; Hypercholesterolemia; Pre-Diabetes
  
• Efficacy of Metformin in PCOS: Metabolic and Hormonal Factors
  ClinicalTrials.gov Identifier: NCT00317928 - Active, not recruiting
  Polycystic Ovary Syndrome
  
• RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes
  ClinicalTrials.gov Identifier: NCT00379769 - Active, not recruiting
  Type 2 Diabetes
  
• Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of Metformin
  ClinicalTrials.gov Identifier: NCT00501020 - Active, not recruiting
  Type 2 Diabetes
  
• Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on
  ClinicalTrials.gov Identifier: NCT00350779 - Active, not recruiting
  Diabetes Mellitus, Type II
  
• A Sub-Study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus Metformin
  ClinicalTrials.gov Identifier: NCT00468039 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Metformin in Assisted Reproduction
  ClinicalTrials.gov Identifier: NCT00159575 - Recruiting
  PCOS- polycystic ovarian syndrome = hormonal and metabolic disease filling at least 2 out of the following 3:; ...
  
• Rosiglitazone Effect on Mitochondria and Lipoatrophy
  ClinicalTrials.gov Identifier: NCT00367744 - Recruiting
  HIV Infections
  
• Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics with Angina
  ClinicalTrials.gov Identifier: NCT00225342 - Not yet recruiting
  Angina Pectoris; Diabetes Mellitus, Type 2
  
• Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The VICTORY Trial
  ClinicalTrials.gov Identifier: NCT00169832 - Active, not recruiting
  Diabetes; Coronary Artery Bypass Grafting
  
• Effect of Rosiglitazone in Nondiabetic Patients With the Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00364221 - Active, not recruiting
  Metabolic Syndrome; Insulin Resistance
  
• The Anti-Inflammatory And Metabolic Effects Of Rosiglitazone In Subjects With Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00379600 - Active, not recruiting
  Rheumatoid Arthritis
  
• The Effect of Adding Metformin to the Treatment of Hepatitis C
  ClinicalTrials.gov Identifier: NCT00560690 - Active, not recruiting
  Hepatitis C
  
• A clinical trial to prevent the complications of insulin resistance (including type-2 diabetes)
  ClinicalTrials.gov Identifier: NCT00015626 - Completed
  Insulin Resistance; Diabetes Mellitus
  
• Rosiglitazone on Microalbuminuria in Type 2 Diabetics
  ClinicalTrials.gov Identifier: NCT00500955 - Active, not recruiting
  Type 2 Diabetes Mellitus; Microalbuminuria
  
• Effects of Rosiglitazone on Serum Ghrelin and Peptide YY Levels
  ClinicalTrials.gov Identifier: NCT00522470 - Recruiting
  Type 2 Diabetes Mellitus; Obesity
  
• Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00182052 - Active, not recruiting
  Adenocarcinoma of the Prostate; Prostate Cancer
  
• Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00098852 - Recruiting
  recurrent thyroid cancer; stage IV follicular thyroid cancer; insular thyroid cancer; stage IV papillary thyroid cancer
  
• Impact of Genetics on Metformin Pharmacokinetics
  ClinicalTrials.gov Identifier: NCT00187798 - Recruiting
  Healthy Volunteer
  
• Efficacy of Vildagliptin 100 MG as Compared to Placebo as Add-on to Metformin in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00351884 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00376038 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
  ClinicalTrials.gov Identifier: NCT00460941 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin
  ClinicalTrials.gov Identifier: NCT00329225 - Active, not recruiting
  Non-Insulin-Dependent Diabetes Mellitus
  
• Efficacy and Safety of Vildagliptin Compared to Placebo on the Incretin Effect in Patients With Type 2 Diabetes Treated With Metformin
  ClinicalTrials.gov Identifier: NCT00396071 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00237237 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Study of SYR-322 Combined With Metformin in the Treatment of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00286442 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Clinical Research Network in Non-alcoholic Steatohepatitis - Pediatric Trial
  ClinicalTrials.gov Identifier: NCT00063635 - Active, not recruiting
  Fatty Liver
  
• Vildagliptin 100 mg Once Daily vs. Placebo as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
  ClinicalTrials.gov Identifier: NCT00494884 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00241605 - Active, not recruiting
  Non-Insulin-Dependent Diabetes Mellitus
  
• Metformin and Oral Contraceptives in PCOS
  ClinicalTrials.gov Identifier: NCT00451568 - Recruiting
  Polycystic Ovary Syndrome
  
• Metformin in Infertile PCOS Patients
  ClinicalTrials.gov Identifier: NCT00501904 - Recruiting
  Polycystic Ovary Syndrome
  
• A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients
  ClinicalTrials.gov Identifier: NCT00349427 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Open-Label Extension Study of Rosiglitazone XR as Adjunctive Therapy in Subjects With Mild-to-Moderate Alzheimer's
  ClinicalTrials.gov Identifier: NCT00490568 - Recruiting
  Alzheimers Disease
  
• Genetic Basis for Variation in the Renal Elimination of Metformin
  ClinicalTrials.gov Identifier: NCT00187720 - Recruiting
  Healthy Volunteer
  
• An RCT of Metformin Vs Orlistat in Obese Anovulatory Women
  ClinicalTrials.gov Identifier: NCT00292799 - Recruiting
  Anovulation; Obesity
  
• The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study
  ClinicalTrials.gov Identifier: NCT00400231 - Recruiting
  Metabolic Syndrome X
  
• Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate
  ClinicalTrials.gov Identifier: NCT00551564 - Recruiting
  Healthy; Overweight; Type 2 Diabetes Mellitus
  
• Metformin Administration in Infertile Anovulatory PCOS Patients
  ClinicalTrials.gov Identifier: NCT00501787 - Recruiting
  Polycystic Ovary Syndrome
  
• 52-Week Add-on to Metformin Comparison of Saxagliptin and Sulphonylurea
  ClinicalTrials.gov Identifier: NCT00575588 - Recruiting
  Type 2 Diabetes
  
• Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) – The ROSITEL Study
  ClinicalTrials.gov Identifier: NCT00486187 - Recruiting
  Type 2 Diabetes Mellitus
  
• The Vascular Effects of Exenatide vs. Metformin in Patients With Pre-Diabetes
  ClinicalTrials.gov Identifier: NCT00546728 - Recruiting
  Impaired Glucose Tolerance
  
• The Impact of Rosiglitazone on Regression of Atherosclerosis
  ClinicalTrials.gov Identifier: NCT00166803 - Recruiting
  Diabetes Mellitus; Atherosclerosis
  
• Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes.
  ClinicalTrials.gov Identifier: NCT00469092 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone.
  ClinicalTrials.gov Identifier: NCT00154011 - Completed
  Healthy subjects
  
• A Study of the Efficacy and Safety of Topiramate in the Treatment of Obese, Type 2 Diabetic Patients Treated With Metformin
  ClinicalTrials.gov Identifier: NCT00231660 - Active, not recruiting
  Diabetes Mellitus, Type 2; Obesity; Diabetes Mellitus, Adult-Onset
  
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00348309 - Recruiting
  Alzheimer Disease
  
• A Study To Demonstrate The Bioequivalence Of Rosiglitazone XR (BRL-049653) 8mgs XR Manufactured At Two Different Sites.
  ClinicalTrials.gov Identifier: NCT00468897 - Recruiting
  Alzheimers Disease
  
• Simvastatin and Metformin Therapy in PCOS Women. Prospective Randomised Trial.
  ClinicalTrials.gov Identifier: NCT00396513 - Recruiting
  Polycystic Ovary Syndrome
  
• Metformin in Non-Alcoholic Fatty Liver Disease
  ClinicalTrials.gov Identifier: NCT00303537 - Active, not recruiting
  Fatty Liver
  
• Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control
  ClinicalTrials.gov Identifier: NCT00283049 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Rosiglitazone (Avandia) Vs Placebo for Androgren- Dependent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00139412 - No longer recruiting
  Prostate Cancer
  
• Therapy for Infertile PCOS Patients Ovulating Under Clomiphene Citrate or Metformin
  ClinicalTrials.gov Identifier: NCT00502229 - Recruiting
  Polycystic Ovary Syndrome; Infertility
  
• Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00337610 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin
  ClinicalTrials.gov Identifier: NCT00519480 - Recruiting
  Type 2 Diabetes
  
• Addition Of Januvia Improves Glycemic Control In Patient In Adequately Controlled By Metformin
  ClinicalTrials.gov Identifier: NCT00545584 - Recruiting
  Diabetes Mellitus, Non-Insulin-Dependent